Neogenomics Inc (NEO)

Cost of Revenue

$109.78M

Quarterly · Period ending: · USD

NEO logo

NEO Cost of Revenue

Latest reported$109.78M
NEO Quarterly Cost of Revenue ($0.00 → $109.78M)
High-resolution chart · PNG

NEO cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
109,778,000
105,808,000
114,459,000
107,351,000
104,072,000
94,789,000
94,743,000
92,944,000
92,008,000
90,771,000
87,964,000
89,643,000
87,026,000
82,406,000
81,880,000
79,889,000
81,126,000
78,937,000
80,475,000
74,101,000
68,734,000
73,959,000
68,544,000
71,379,000
58,971,000
59,661,000
56,945,000
53,840,000
52,747,000
48,462,000
39,364,000
36,775,000
37,216,000
36,120,000
34,660,000
34,242,000
34,912,000
34,480,000
33,232,000
33,416,000
34,524,000
32,531,000
15,051,000
13,955,000
13,557,000
13,482,000
13,528,000
12,923,000
10,431,000
9,473,000
9,160,000
8,713,000
8,446,000
8,411,000
8,460,000
8,310,000
8,244,000
8,016,000
7,060,000
6,246,000
5,810,000
4,940,000
4,851,000
4,818,000
4,575,000
4,344,000
4,107,000
3,672,000
3,384,000
3,090,000
2,776,000
2,535,000
2,184,000
1,858,000
1,899,000
1,521,000
1,166,000
936,734
735,711
720,866
725,816
576,797
504,708
313,176
182,391
164,614
159,734
132,773
138,374
145,986
145,959
127,418
111,173
97,043
53,196
61,033
70,894
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.